-
Original Article
-
- Incidence and prevalence of adult-onset Still’s disease in South Korea: a 20-year nationwide population-based study
-
-
1Department of Internal Medicine, Konyang University School of Medicine, Daejeon, Korea
2Konyang University, Myunggok Medical Research Center, Daejeon, Korea
3Department of Preventive Medicine, Jeonbuk National University College of Medicine, Jeonju, Korea
4Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea
- Corresponding author: Younghee Jung ,Tel: +82-42-280-7126, Fax: +82-42-280-6970, Email: jubaragiy@cnu.ac.kr
- Received: February 4, 2026; Revised: March 26, 2026 Accepted: April 21, 2026.
- Abstract
- Background/Aims
Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder with limited population-based epidemiological data. We estimated the nationwide incidence and prevalence of AOSD in South Korea and assessed temporal trends. As a secondary exploratory aim, we also examined claims-based treatment trajectories.
Methods
We conducted a nationwide retrospective cohort study using Korean National Health Insurance Service claims data from 2002 to 2022. Annual incidence and prevalence were age- and sex-standardised to the 2019 Korean population. Temporal trends were evaluated using log-linear regression and one-joinpoint analyses. Patients were additionally grouped according to claims-based medication trajectories.
Results
Among 15,000 individuals with an AOSD diagnostic code, 4,825 met the case definition; 4,600 incident cases diagnosed during 2003–2022 were included. Age- and sex-adjusted annual incidence remained below 1 per 100,000 population (0.28–0.75), with no significant overall temporal change (annual percent change [APC], 1.41%; 95% confidence interval [CI], –0.58 to 3.44; p = 0.155). Age- and sex-adjusted prevalence increased from 0.91 per 100,000 in 2003 to 10.02 per 100,000 in 2022 (APC, 12.51%; 95% CI, 10.56 to 14.50; p < 0.001). Across successive 5-year periods, the proportion of female patients decreased from 72.9% to 66.1%, whereas mean age at diagnosis increased from 41.7 to 47.5 years. Under prespecified operational rules, 3.0% of patients were grouped as monocyclic, 39.6% as polycyclic, 17.7% as chronic, and 39.6% as unclassified.
Conclusions
AOSD in South Korea is rare, with low overall incidence but steadily increasing prevalence. Exploratory treatment trajectory analyses may complement population-level epidemiological assessment.
Keywords :Still's disease, adult-onset; Epidemiology; Administrative claims, healthcare